These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 352035)

  • 1. [Comparison of three serological methods for determination of antistreptokinase following fibrinolytic therapy (author's transl)].
    Knöll H; Gerlach D; Knöll P; Vogel G
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):313-9. PubMed ID: 352035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antistreptokinase antibodies and outcome of fibrinolytic therapy with streptokinase for left-sided prosthetic valve thrombosis.
    Singh S; Doshi S; Salahuddin S; Tarik M; Barwad P; Ramakrishnan L; Ramakrishnan S; Karthikeyan G; Bhargava B; Bahl VK
    Am Heart J; 2015 Jan; 169(1):170-4. PubMed ID: 25497263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid detection and quantitation of precipitating streptokinase-antibodies.
    Spöttl F; Kaiser R
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):608-16. PubMed ID: 4217476
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.
    Fears R; Ferres H; Glasgow E; Standring R; Hogg KJ; Gemmill JD; Burns JM; Rae AP; Dunn FG; Hillis WS
    Br Heart J; 1992 Aug; 68(2):167-70. PubMed ID: 1389731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptokinase immunogenicity in thrombolytic therapy for acute myocardial infarction.
    Rosenschein U; Lenz R; Radnay J; Ben Tovim T; Rozenszajn LA
    Isr J Med Sci; 1991 Oct; 27(10):541-5. PubMed ID: 1955306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New findings concerning the anti-streptokinase titre in relation to a streptokinase-induced thrombolytic therapy (author's transl)].
    Bruhn HD
    Dtsch Med Wochenschr; 1974 Jun; 99(26):1410-1. PubMed ID: 4276043
    [No Abstract]   [Full Text] [Related]  

  • 7. Do recipients of kidneys from donors treated with streptokinase develop anti-streptokinase antibodies?
    Mi H; Gupta A; Gok MA; Asher J; Shenton BK; Stamp S; Carter V; Del Rio Martin J; Soomro NA; Jaques BC; Manas DM; Talbot D
    Transplant Proc; 2005 Oct; 37(8):3272-3. PubMed ID: 16298569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptokinase resistance: when might streptokinase administration be ineffective?
    Buchalter MB; Suntharalingam G; Jennings I; Hart C; Luddington RJ; Chakraverty R; Jacobson SK; Weissberg PL; Baglin TP
    Br Heart J; 1992 Nov; 68(5):449-53. PubMed ID: 1467027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The therapeutic use of streptokinase in the treatment of shock lung (author's transl)].
    Harke H
    Anaesthesist; 1979 Jun; 28(6):259-70. PubMed ID: 464250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antistreptokinase antibodies following a dose of streptokinase.
    Chesser SL; Mauro VF
    Ann Pharmacother; 1994 Feb; 28(2):204-6. PubMed ID: 8173136
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibody pattern in patients with different forms of leishmaniasis (author's transl)].
    Mannweiler E; Lederer I; zum Felde I
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):397-402. PubMed ID: 352039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Assessment of antistreptokinase titer in a hospital population].
    Rymaszewski Z; Berent H; Uchman E; Kancelarczyk W
    Pol Tyg Lek; 1976 Sep; 31(37):1601-3. PubMed ID: 980976
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antistreptokinase titer after fibrinolysis treatment].
    Theiss W
    Dtsch Med Wochenschr; 1990 Jun; 115(23):918-9. PubMed ID: 2354666
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypersensitivity reactions to streptokinase in patients with high pre-treatment antistreptokinase antibody and neutralisation titres.
    Lee HS; Yule S; McKenzie A; Cross S; Reid T; Davidson R; Jennings K
    Eur Heart J; 1993 Dec; 14(12):1640-3. PubMed ID: 8131761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of the bleeding mechanism during fibrinolysis induced by streptokinase in the rabbit (author's transl)].
    Bara L; Samama M; Bilski-Pasquier G; Bloch MF; Rochas S
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():48-54. PubMed ID: 353658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Eighteen years' experience of thrombolytic therapy with streptokinase (author's transl)].
    Hess H
    MMW Munch Med Wochenschr; 1980 Nov; 122(48):1735-8. PubMed ID: 6779140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raised levels of antistreptokinase antibody and neutralization titres from 4 days to 54 months after administration of streptokinase or anistreplase.
    Lee HS; Cross S; Davidson R; Reid T; Jennings K
    Eur Heart J; 1993 Jan; 14(1):84-9. PubMed ID: 8432298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of anti-streptokinase antibody levels in human sera using a microradioimmunoassay procedure.
    Moran DM; Standring R; Lavender EA; Harris GS
    Thromb Haemost; 1984 Dec; 52(3):281-7. PubMed ID: 6531752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy.
    Elliott JM; Cross DB; Cederholm-Williams SA; White HD
    Am J Cardiol; 1993 Mar; 71(8):640-5. PubMed ID: 8447258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies of the heterogeneity of streptokinases of different origin (author's transl)].
    Gerlach D; Köhler W
    Zentralbl Bakteriol Orig A; 1977 Jul; 238(3):336-49. PubMed ID: 410199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.